open menu
About us
Innovation
Quality & compliance
Sustainability
News
Careers
Investors
Buy from VWR
Home
Newsroom
Home
/
Newsroom
/
Press Releases
Press Releases
In the News
Media Resources
Investor Relations
Press Releases
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Year
All Years
2024
2023
2022
2021
2020
2019
Category
All Categories
CORPORATE
BIOPHARMA
RESEARCH
SUSTAINABILITY
Uncategorized
Keywords
Go
Advanced Search
Search
Search Headlines Only
Category
All Categories
CORPORATE
BIOPHARMA
RESEARCH
SUSTAINABILITY
Uncategorized
From
To
Asset Types
Video
Audio
Photos
Documents
Events
Standard
Nov 5, 2019
Avantor Reports Third Quarter 2019 Results
CORPORATE
- Net sales of $1.50 billion, net income of $22.1 million, adjusted EBITDA of $250.8 million
Oct 22, 2019
Avantor® to Report Third Quarter Earnings and Host Earnings Call on Tuesday, November 5
CORPORATE
Oct 21, 2019
Avantor® Declares Dividend on Mandatory Convertible Preferred Stock
CORPORATE
Sep 4, 2019
Avantor® to Participate in the Morgan Stanley Global Healthcare Conference
CORPORATE
Aug 6, 2019
Avantor Reports Second Quarter 2019 Results
CORPORATE
- Net sales of $1.53 billion, up 4% (6% on an organic basis)
Show
5
10
25
50
100
per page
«
1
…
33
34
35
36
37
38
39
40
41
»
